Clinical Efficacy of Atomoxetine for Methamphetamine Dependence
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the ability of atomoxetine compared to placebo to
increase time to relapse in methamphetamine dependent volunteers. Our hypothesis is that
atomoxetine will increase time before (if) the participant relapses.